Myomectomy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 1,149.53 million by 2028 and will grow at a CAGR of 8.67% in the above mentioned forecast period.
Myomectomy is also known as fibroidectomy, is the process of surgical removal of uterine leiomyomas, also known as fibroids. Contrary to a hysterectomy, the uterus remains conserved and the woman keeps her reproductive potential.
Request For a Sample Copy of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-myomectomy-market
The rapid rise in the number of patients suffering from uterine fibroids and associated conditions is amongst the important factor expected to intensify the growth and demand of myomectomy market. In addition, the rise in the number of less invasive procedures and the high adoption of technologically advanced devices for safe and effective myomectomy procedures are also expected contributes to the growth in the global market over the forecast period of 2021 to 2028. Also the rise in the geriatric population and rise in the popularity of minimally invasive and non-invasive myomectomy procedures such as laparoscopic and robot-assisted myomectomy surgeries are also likely to enhance the growth of the market. Furthermore, the increase in the number of initiatives being implemented by government and non-profit organizations in conjunction various medical facilities to improve the treatment or assistance are also amongst the significant factors expected to fuel the growth of the myomectomy market.
The high demand for minimally invasive procedures, rapid advancement in healthcare technology and the well-developed healthcare infrastructure in the developing countries are anticipated to offer significant growth opportunities for the myomectomy market in the forecast period of 2021 to 2028.
North America region leads the myomectomy market owing to the increase in the number of patients suffering from uterine fibroid problems and high medical reimbursement facilities. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rise in the women population suffering from uterine fibroids, increase in awareness regarding disease diagnosis and treatment and rapid modernization of healthcare infrastructure.
The major players covered in the myomectomy market report are Boston Scientific Corporation, CooperSurgical Inc., F. Hoffmann-La Roche Ltd., KARL STORZ SE & Co. KG, Richard Wolf GmbH, AbbVie Inc., Johnson & Johnson Services, Inc., Medtronic, Stryker, CONMED Corporation, Hologic, Inc., and B. Braun Melsungen AG among other domestic and global players.
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Myomectomy Market HighlightsMyomectomy is surgical procedure for the removal of uterine fibroids.
Heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramps are major symptoms for uterine fibroids.Prevalence of uterine disorders abnormal uterine bleeding (AUB), amenorrhea, dysmenorrhea (painful menstrual periods, and premenstrual syndrome (PMS) is on the rise across the globe, especially in the developing countries.
In addition, increasing research and development activities, and technological advancements to identify the causes and risk factors for such disorders is fuelling the global myomectomy market growth.
There is also an increasing demand for technologically advanced devices for the diagnosis of uterine fibroids.
The key players are now focusing on the geographical expansion in the developing regions such as Asia Pacific.Uterine fibroids affects nearly 40% of women in the age group of 30 and 55, including 20 million women in North America and 24 million women in Europe with over 7 million patients worldwide presently undergo various symptom management treatments.The global myomectomy market is expected to grow at a CAGR of 6.9% during the forecast period.Myomectomy Market Regional AnalysisIn the Americas, the market for myomectomy is found to be growing from the last few years and expected to exhibit tremendous growth during the forecast period.
Rising prevalence of uterine disorders, and other reproductive health problems, emphasis on healthy lifestyle, and availability of specialized healthcare services conditions are important drivers for the growth of the market.
